SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GlycoGenesys GLGS (formerly SafeScience SAFS) -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (38)5/4/2005 6:16:51 PM
From: tuck  Read Replies (1) | Respond to of 56
 
Paid report by a Scimitar analyst:

scimitarequity.com

Calls it a buy. Yeah, maybe now that it's utterly cratered to the point that it again has listing issues.

An NDA in multiple myeloma by 2007? Seem a little ambitious to anyone? Apparently there's some work by Dana Farber people showing GLGS compound has promise in bortezomib-refractory MM, which is indeed interesting.

Cheers, Tuck